ACE and Alzheimer disease: In opposition, MacLachlan et al. found that in normal ageing, human brain homogenates presented increase of ACE1 and AngII protein levels and decrease of ACE1 activity whereas in early stages of AD it was observed increased ACE1 activity and unchanged ACE1 and AngII protein levels (MacLachlan et al., 2022).